Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work With Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work With Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Dupilumab Shows Effectiveness in Paediatric Atopic Dermatitis
September 2026
A three-year cohort study found sustained dupilumab effectiveness and safety in children with atopic dermatitis, with higher itch and quality-of-life impairment among younger children.
Read more
28 Sep 2026
Dupilumab Shows Effectiveness in Paediatric Atopic Dermatitis
A three-year cohort study found sustained dupilumab effectiveness and safety in children with atopic dermatitis, with higher itch and quality-of-life impairment among younger children.
25 Sep 2026
Generalised Pustular Psoriasis Linked to Higher Mortality
A population-based study found rising generalised pustular psoriasis prevalence in England, alongside increased mortality risk and reduced life expectancy.
23 Sep 2026
Psoriasis Treatments Show Distinct Infection Risks
A nationwide cohort study found rare tuberculosis and meningitis among patients receiving systemic psoriasis treatments, while IL-17 inhibitors were associated with higher candidiasis risk.
21 Sep 2026
Omalizumab Drug Survival Remains High in Chronic Urticaria
Omalizumab drug survival reached 3.1 years in chronic urticaria, with autoimmune and atopic comorbidities linked to distinct discontinuation patterns.
18 Sep 2026
Efgartigimod Shows No Clinical Benefit in Pemphigus
A phase III trial found no clinical benefit from efgartigimod plus prednisone over prednisone alone in moderate-to-severe pemphigus.
16 Sep 2026
CD1a Autoreactivity Reveals Skin Barrier Compromise
Research suggests CD1a-autoreactive T cells may sense chronic skin barrier compromise through altered sphingomyelin activity, linking lipid processing with immune activation in atopic dermatitis.
14 Sep 2026
Mohs Surgery Shows Similar Five-Year CSCC Recurrence Rates
MMS showed no significant difference in five-year CSCC recurrence versus standard excision, while producing smaller surgical defects.
11 Sep 2026
Hereditary Hypotrichosis Shows Distinct Genetic Patterns
A Chinese multicentre cohort identified 11 causative genes and distinct genotype–phenotype patterns in non-syndromic hereditary hypotrichosis.
Loading posts...
1
2
3
…
56
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View